It is a process where new blood vessel growth is stimulated by the secretion of proangiogenic factors, such as vascular endothelial growth factor (VEGF), in response to relative hypoxic conditions in areas within the tumor where there is relatively little blood supply. The gene discussed is VEGFA; the disease is neoplasm.